Clinical Trial Update: Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) [Phase 2]

View source ↗

Summary

Phase 2 trial on co-administration of tesofensine and metoprolol in Prader-Willi syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)
• Tesofensine (tesofensine)

Snippet

Sponsor: Saniona | Conditions: Confirmed Genetic Diagnosis of Prader-Willi Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-02-26